Indication
Lung Injury
6 clinical trials
11 products
Clinical trial
The Efficacy of P0.1-guided Sedation Protocol in Critically Ill Patients Receiving Invasive Mechanical Ventilation: A Randomized Controlled TrialStatus: Recruiting, Estimated PCD: 2025-02-01
Product
FentanylProduct
MidazolamProduct
PropofolProduct
DexmedetomidineProduct
CisatracuriumClinical trial
Inhibition of Plasma Kallikrein as a New Therapy for Lung InjuryStatus: Active (not recruiting), Estimated PCD: 2024-12-01
Product
LanadelumabClinical trial
Effect of Human Umbilical Cord-derived Mesenchymal Stem Cells on Non-cardiac Surgery-induced Lung Injury in Patients With Ischemic Heart DiseaseStatus: Recruiting, Estimated PCD: 2023-12-01
Clinical trial
SAFEty Study of Early Infusion of Vitamin C for Treatment of Novel Coronavirus Acute Lung Injury (SAFE EVICT CORONA-ALI)Status: Completed, Estimated PCD: 2022-06-10
Product
L-ascorbic acidClinical trial
Effect of Inhalational Sedation on Mechanical Power in Mechanically Ventilated Patients: a Pilot Open-label Randomized Controlled StudyStatus: Recruiting, Estimated PCD: 2023-05-01
Product
Inhalational sedationProduct
Convention sedationClinical trial
To Study the Clinical Treatment Plan of Lung Injury Caused by Major Infectious Diseases Treated With Stem CellsStatus: Recruiting, Estimated PCD: 2026-05-10
Product
Mesenchymal Stem Cells